Comparison of the efficacy of oral fluconazole and oral Terbinafine in the treatment of moderate to severe seborrheic dermatitis
Phase 2
- Conditions
- Seborrhoeic dermatitis.Seborrhoeic dermatitis
- Registration Number
- IRCT201102205871N1
- Lead Sponsor
- Gilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Patients with moderate to severe seborrheic dermatitis¸ filling the consent form,no previous treatment history at least 2 weeks before entering the study such as steroids, antifungal agents.
Exclusion criteria:Lactation ¸ pregnancy ¸ no pervious diseases such as renal and liver failure, psoriasis, documented human immunodeficiency virus infection and/or sensitivity to fluconazole and terbinafine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SDASI (Seborrheic dermatitis area severity index). Timepoint: weeks 4 , 6. Method of measurement: Determine severity of disease by examiner according to SDASI.;Itch. Timepoint: 4 weeks later and 6 weeks later. Method of measurement: subjective.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: at first,two and four weeks after treatment. Method of measurement: history,physical exam, laboratory tests.